MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30.

Income Overview

Net Income
-$3,035K
EPS
-$0.34
Unit: Thousand (K) dollars

Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Revenue
-2,733 57 55*
Research and development
2,311 2,291 2,506 -768*
Acquired in-process research and development
----124,291*
General and administrative
1,744 1,691 2,754 4,104*
Total operating expenses
4,055 3,982 5,260 -120,956*
Gain from operations
-4,055 -1,249 -5,203 121,011*
Change in fair value of warrant liability
3 -146 -26,513 6,110*
Other income, net
96 188 180 -110*
Net (gain) income
-3,962 -915 21,490 114,791*
Net (loss) income attributable to series c preferred stockholders, basic
--290 6,407 -27,962*
Net (loss) income attributable to common stockholders, basic
-3,035 -625 15,083 142,753
Basic EPS
-0.34 -0.11 2.17 91.939
Diluted EPS
-0.34 -0.11 2.09 91.939
Basic Average Shares
8,818,859 5,820,903 6,965,927 1,552,685*
Diluted Average Shares
8,818,859 5,820,903 7,215,125 1,552,685*
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net (loss) incomeattributable to common...-$3,035K something is missing$927K Net (gain) income-$3,962K (53.25%↑ Y/Y)Other income, net$96K (57.38%↑ Y/Y)Gain from operations-$4,055K (52.50%↑ Y/Y)Change in fair value ofwarrant liability$3K Total operatingexpenses$4,055K (-52.81%↓ Y/Y)Research and development$2,311K (-54.80%↓ Y/Y)General andadministrative$1,744K (-49.89%↓ Y/Y)

Traws Pharma, Inc. (TRAW)

Traws Pharma, Inc. (TRAW)